Company news
Medicure Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Medicure Closes Acquisition of Majority Interest in Apicore
December 1, 2016
Medicure to Hold Investor Call on November 21, 2016
November 18, 2016
Medicure Exercises Option to Acquire Majority Interest in Apicore
November 18, 2016
Medicure Reports Third Quarter 2016 Financial Results
November 9, 2016
Medicure to Announce Q3 2016 Financial Results on November 9, 2016
November 2, 2016
FDA Approves New AGGRASTAT® Product Format
September 1, 2016
Medicure Reports Second Quarter 2016 Financial Results
August 10, 2016
Medicure to Announce Q2 2016 Financial Results on August 10, 2016
August 3, 2016
Medicure Receives Response Letter from FDA on AGGRASTAT® sNDA for New Indication
July 7, 2016
Medicure Reports First Quarter 2016 Financial Results
May 11, 2016
Medicure Files Application for New AGGRASTAT® Product Format
May 11, 2016
Medicure Announces Departure of President and Chief Operating Officer
May 9, 2016
Medicure to Announce Q1 2016 Financial Results on May 11, 2016
May 4, 2016
Medicure Announces Grant of Options
April 7, 2016
Medicure Announces Upcoming Conference Presentations
April 5, 2016
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2015
March 30, 2016
Medicure To Announce Fiscal Year 2015 Financial Results on March 30, 2016
March 23, 2016
Meta-Analysis of AGGRASTAT® (Tirofiban HCl) Presented at CRT 2016 Conference
February 23, 2016
Medicure to present at Cantech Investment Conference
January 21, 2016
Medicure Announces Preliminary Revenue For Fiscal 2015
January 11, 2016
Medicure announces ANDA collaboration with Apicore
January 6, 2016
Medicure Announces PDUFA Action Date for New Aggrastat Indication
December 2, 2015
Medicure Reports Third Quarter 2015 Financial Results
November 9, 2015
PI Financial Initiates Coverage on Medicure Inc. with a $5.75 Target Price - Video Research Alert on InvestmentPitch.com
October 20, 2015
Medicure Announces Filing of sNDA for New AGGRASTAT® Indication
September 10, 2015
Medicure Reports Second Quarter 2015 Financial Results
August 11, 2015
Medicure Q2 Results And Conference Call Dates
August 5, 2015
Medicure Announces Grant Of Options
July 7, 2015
Medicure Closes Bought Deal Private Placement Financing for Gross Proceeds of $4,025,000
June 26, 2015
Medicure Announces $3.5 Million "Bought Deal" Private Placement
June 10, 2015
TSX Venture Exchange Cease Trade Order
May 6, 2015
Medicure Reports Financial Results for the First Quarter of 2015
April 29, 2015
Medicure Announces Approval of Expanded Dosing Time For AGGRASTAT®
April 23, 2015
Medicure to present at the 2015 Bloom Burton & Co. Healthcare Conference
April 22, 2015
Medicure reports financial results for the seven months ended December 31, 2014
April 14, 2015
Medicure announces grant of options
March 27, 2015
Medicure announces issuance of shares under previously announced shares for debt settlement
March 20, 2015
Medicure provides quarterly revenue on a calendar basis following change to year end
February 2, 2015
Medicure announces shares for debt settlements
January 27, 2015
Medicure Announces Change in Fiscal Year End and Provides One-Time Guidance on Quarterly Revenue
December 18, 2014
MicroPlanet Expands Executive and Closes Financing
April 4, 2013
MicroPlanet Announces Follow-On Order From Australian Utility
January 30, 2013
MicroPlanet Announces Multi-Year, Multi-Million Dollar Licensing Agreement
November 13, 2012
MicroPlanet Closes Second Tranche of Private Placement of Common Shares and Issuance of Shares for Debt
October 12, 2012
MicroPlanet Announces Changes to Board of Directors
August 17, 2012
MicroPlanet Voltage Regulation Products Receive CSA / EN / and UL Standards Certifications
August 16, 2012
MicroPlanet Reports 2012 Q2 Results
August 15, 2012
MicroPlanet Closes Final Tranche Of Private Placement Of Convertible Notes, Enters Shares For Debt Agreements, And Closes First Tranche Of Equity Financing
July 31, 2012
MicroPlanet Announces Amendment to Terms of Recent Private Placement of Convertible Notes
July 9, 2012
MicroPlanet Closes Private Placement, Extension of Existing Notes
June 19, 2012
Calls
The 5 newest of 24 calls. Every call is listed under its year.
- Medicure (TSXV:MPH) Q2 2026 Earnings Call
Aug 17, 2026
Transcript - Medicure (TSXV:MPH) Q1 2026 Earnings Call
May 25, 2026
Transcript - Medicure (TSXV:MPH) Q4 2025 Earnings Call
Apr 27, 2026
Transcript - Medicure (TSXV:MPH) Q3 2025 Earnings Call
Nov 20, 2025
Transcript - Medicure (TSXV:MPH) Q2 2025 Earnings Call
Aug 21, 2025
Transcript
Decks
The 5 newest of 21 decks. Every deck is listed under its year.
- Investor Presentation (August 2026)
Investor deck · 15 slides · Aug 6, 2026
- Q1 2026 Earnings Presentation
Earnings · 15 slides · May 25, 2026
- Investor Presentation (May 2025)
Investor deck · 15 slides · May 22, 2025
- Investor Presentation (September 2023)
Investor deck · 15 slides · Sep 27, 2023
- Investor Presentation (April 2023)
Investor deck · 15 slides · April 2023